المؤلفون: Pont, LG, Nielen, JTH, McLachlan, AJ, Gnjidic, D, Chan, L, Cumming, RG, Taxis, K

المساهمون: Methods in Medicines evaluation & Outcomes research (M2O), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R5 - Optimising Patient Care

المصدر: British Journal of Clinical Pharmacology, 80(5), 1169-1175. Wiley

مصطلحات موضوعية: Male, drug exposure, adverse outcome, Drug-Related Side Effects and Adverse Reactions, Anticholinergic drug exposure, Anticholinergic burden, population, Therapeutics, Cholinergic Antagonists, BURDEN INDEX, PEOPLE, Drug utilization, cholinergic receptor blocking agent, cross-sectional study, Humans, COHORT, Pharmacology & Pharmacy, human, Longitudinal Studies, phenformin, ASSOCIATIONS, risk, Aged, Aged, 80 and over, Australian, RISK SCALE, MEDICATIONS, Methodology, Australia, FALLS, INPATIENTS, ADULTS, Cross-Sectional Studies, classification, Pharmaceutical Preparations, community, 1115 Pharmacology and Pharmaceutical Sciences, Older people

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b7d219044fbc8a1f7043af9cd3a2d0db
https://europepmc.org/articles/PMC4631189/

المؤلفون: Werkman NCC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Driessen JHM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands., Schaper NS; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center+, Maastricht, The Netherlands., Souverein PC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands., Stehouwer CDA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands., Nielen JTH; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3764-3780. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Foot*/drug therapy , Diabetic Foot*/epidemiology , Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Incretins*/therapeutic use , Incretins*/adverse effects , Amputation, Surgical*/statistics & numerical data , Glucagon-Like Peptide-1 Receptor*/agonists , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Cohort Studies ; Sulfonylurea Compounds/therapeutic use ; Sulfonylurea Compounds/adverse effects ; Hospitalization/statistics & numerical data ; Insulin/therapeutic use ; Metformin/therapeutic use ; Metformin/adverse effects ; Proportional Hazards Models

المؤلفون: Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands., García-Sáez G; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Nielen JTH; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands. yannick.nielen@mumc.nl.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands. yannick.nielen@mumc.nl., Tapia-Galisteo J; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Somolinos-Simón FJ; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain., Hernando ME; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Wang J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Jiu L; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; National Health Care Institute, Diemen, the Netherlands., van der Kallen CJH; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands., Koster A; Department of Social Medicine, Maastricht University, Maastricht, the Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands., Schalkwijk CG; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands., de Vries H; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., de Vries NK; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands., Eussen SJPM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands., Stehouwer CDA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands.

المصدر: Diabetologia [Diabetologia] 2024 Apr; Vol. 67 (4), pp. 690-702. Date of Electronic Publication: 2024 Jan 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2* , Diabetes Complications* , Insulin Resistance*, Humans ; Quality of Life ; Insulin

المؤلفون: Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands., Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands.; School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands., Stehouwer CDA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands., Vestergaard P; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.; Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark., Schaper NC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center+, Maastricht, The Netherlands., van den Bergh JP; School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands., Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands. yannick.nielen@mumc.nl.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Jun 29; Vol. 22 (1), pp. 160. Date of Electronic Publication: 2023 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Diabetic Foot*/diagnosis , Diabetic Foot*/epidemiology , Diabetic Foot*/surgery, Humans ; Cohort Studies ; Glucagon-Like Peptide-1 Receptor ; Retrospective Studies ; Sodium-Glucose Transporter 2 ; State Medicine ; Amputation, Surgical/adverse effects ; Lower Extremity ; Glucose ; Sodium

المؤلفون: Røikjer J; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University medical Centre+, Maastricht, the Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Ejskjaer N; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.; Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark., van den Bergh JPW; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, VieCuri Medical Centre, Venray, the Netherlands.; Biomedical Research Centre, Hasselt University, Hasselt, Belgium., Vestergaard P; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.; Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark., Schaper NC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.; Division of Endocrinology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands., Jensen MH; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Klungel O; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., de Vries F; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University medical Centre+, Maastricht, the Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University medical Centre+, Maastricht, the Netherlands., Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University medical Centre+, Maastricht, the Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.

المصدر: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2022 Apr; Vol. 39 (4), pp. e14725. Date of Electronic Publication: 2021 Oct 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/epidemiology , Diabetic Foot*/complications , Diabetic Foot*/epidemiology , Diabetic Foot*/therapy, Hospitalization ; Humans ; Incidence ; Risk Factors

المؤلفون: van Veelen A; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands; CARIM School for Cardiovascular Disease, Maastricht University Medical Centre+, Maastricht, the Netherlands. Electronic address: ard.van.veelen@mumc.nl., Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands., van Geel R; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands; CARIM School for Cardiovascular Disease, Maastricht University Medical Centre+, Maastricht, the Netherlands., Croes S; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands; CARIM School for Cardiovascular Disease, Maastricht University Medical Centre+, Maastricht, the Netherlands.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Dec; Vol. 85 (6), pp. e357. Date of Electronic Publication: 2019 Feb 13.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Hydrochlorothiazide*/adverse effects , Skin Neoplasms*/chemically induced , Skin Neoplasms*/epidemiology, Case-Control Studies ; Denmark/epidemiology ; Humans

المؤلفون: Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands., Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, Netherlands., van den Bergh JPW; School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, Netherlands., Ejskjaer N; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Røikjer J; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Schaper NC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands., Rossi B; Directorate Pharmaceutical Affairs, Department for Policy in Health, Ministry for Health, Valletta, Malta., Klungel O; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, Netherlands., Vestergaard P; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., de Vries F; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands., Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.

المصدر: Current drug safety [Curr Drug Saf] 2021; Vol. 16 (1), pp. 62-72.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Saif Zone, Sharjah, U.A.E. Country of Publication: United Arab Emirates NLM ID: 101270895 Publication Model: Print Cited Medium: Internet ISSN: 2212-3911 (Electronic) Linking ISSN: 15748863 NLM ISO Abbreviation: Curr Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects, Adolescent ; Adult ; Amputation, Surgical ; Cohort Studies ; Glucose ; Humans ; Hypoglycemic Agents/adverse effects ; Lower Extremity/surgery ; Sodium ; Sodium-Glucose Transporter 2

المؤلفون: Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht., Driessen JHM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht.; School for nutrition, and translational research in metabolism (NUTRIM), Maastricht University., Dagnelie PC; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; School for Public Health and Primary Care (CAPHRI), Maastricht University., Boonen A; School for Public Health and Primary Care (CAPHRI), Maastricht University.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center +, Maastricht., van den Bemt B; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Department of Pharmacy, Sint Maartenskliniek.; Department of Pharmacy, Radboud University Medical Center, Nijmegen., van Onzenoort HAW; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Department of Clinical Pharmacy, Amphia Hospital, Breda., Neef C; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center., Henry RMA; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Burden AM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Eidgenossische Technische Hochschule Zurich, Zurich, Switzerland., Sep SJS; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., van der Kallen CJ; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Schram MT; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Schaper N; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Stehouwer CDA; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Smits L; Department of Epidemiology, Maastricht University., de Vries F; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht.

المصدر: Medicine [Medicine (Baltimore)] 2020 Jan; Vol. 99 (1), pp. e18524.

نوع المنشور: Comparative Study; Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Drug Utilization/*statistics & numerical data , Population Health/*statistics & numerical data, Aged ; Anti-Anxiety Agents/therapeutic use ; Female ; Humans ; Hypnotics and Sedatives/therapeutic use ; Male ; Middle Aged ; Netherlands/epidemiology ; Prospective Studies ; Respiratory System Agents/therapeutic use

المؤلفون: Denissen KFM; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands. karlijn.denissen@maastrichtuniversity.nl.; CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands. karlijn.denissen@maastrichtuniversity.nl., Boonen A; CAPHRI Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Nielen JTH; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; CAPHRI Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Feitsma AL; FrieslandCampina, Stationsplein 4, PO Box 1551, 3800 BN, Amersfoort, The Netherlands., van den Heuvel EGHM; FrieslandCampina, Stationsplein 4, PO Box 1551, 3800 BN, Amersfoort, The Netherlands., Emans PJ; Department of Orthopaedics, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands., Stehouwer CDA; Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., Sep SJS; CAPHRI Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; Division of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; Department of Rehabilitation Medicine, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., van Dongen MCJM; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; CAPHRI Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., Dagnelie PC; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; CAPHRI Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., Eussen SJPM; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.

المصدر: European journal of nutrition [Eur J Nutr] 2019 Oct; Vol. 58 (7), pp. 2693-2704. Date of Electronic Publication: 2018 Sep 21.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Steinkopff Country of Publication: Germany NLM ID: 100888704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-6215 (Electronic) Linking ISSN: 14366207 NLM ISO Abbreviation: Eur J Nutr Subsets: MEDLINE

مواضيع طبية MeSH: Dairy Products/*statistics & numerical data , Diet/*methods , Osteoarthritis, Knee/*epidemiology, Adult ; Aged ; Animals ; Cheese/statistics & numerical data ; Cross-Sectional Studies ; Diet/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Milk/statistics & numerical data ; Netherlands/epidemiology ; Prospective Studies ; Risk Factors ; Yogurt/statistics & numerical data

المؤلفون: Nielen JTH; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands; Department of Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands., Dagnelie PC; Department of Epidemiology, CAPHRI School for Public Health and Primary Care, and CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands., Boonen A; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center+, Maastricht, the Netherlands., Klungel O; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands., van den Bemt B; Department of Pharmacy, Sint Maartenskliniek, Nijmegen, the Netherlands; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands., de Vries F; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands. Electronic address: f.devries@uu.nl.

المصدر: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2019 Feb; Vol. 148, pp. 240-248. Date of Electronic Publication: 2019 Jan 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8227 (Electronic) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE

مواضيع طبية MeSH: Diagnostic Techniques, Endocrine*/standards , Diagnostic Techniques, Endocrine*/statistics & numerical data, Diabetes Mellitus, Type 2/*complications , Diabetes Mellitus, Type 2/*epidemiology , Osteoarthritis/*diagnosis , Osteoarthritis/*epidemiology, Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Arthroplasty, Replacement/statistics & numerical data ; Case-Control Studies ; Databases, Factual/statistics & numerical data ; Female ; Humans ; Information Storage and Retrieval/standards ; Information Storage and Retrieval/statistics & numerical data ; Male ; Middle Aged ; Osteoarthritis/complications ; Osteoarthritis/therapy ; Practice Patterns, Physicians'/statistics & numerical data ; Time Factors